MAP3K8 antibody (AA 414-445) (HRP)
Quick Overview for MAP3K8 antibody (AA 414-445) (HRP) (ABIN1911794)
Target
See all MAP3K8 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 414-445
-
Specificity
- This COT (MAP3K8/MEKK8) antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 414-445 amino acids from the C-terminal region of human COT (MAP3K8/MEKK8).
-
Purification
- Protein G purified
-
Isotype
- IgG
-
-
-
-
Application Notes
-
Approved: ELISA, IHC, WB
Usage: The applications listed have been tested for the base form of this product. Alternate forms, such as conjugated, azide-free, or ready-to-use, have not been tested. -
Comment
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- PBS, pH 7.2. No preservative added (azide free)
-
Preservative
- Azide free
-
Handling Advice
- Aliquot to avoid repeated freezing and thawing.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- Short term: store at 4°C. Long term: aliquot and store -20°C for up to 6 months. Avoid freeze-thaw cycles. Protect from light.
-
Expiry Date
- 6 months
-
-
- MAP3K8 (Mitogen-Activated Protein Kinase Kinase Kinase 8 (MAP3K8))
-
Alternative Name
- MAP3K8 / TPL2
-
Background
-
Name/Gene ID: MAP3K8
Subfamily: MAP3K
Family: Protein Kinase
Synonyms: MAP3K8, C-COT, Cancer Osaka thyroid oncogene, COT, Ewing sarcoma transformant, EST, MEKK8, Proto-oncogene c-Cot, TPL2, Tumor progression locus 2, Protein kinase cot, Tpl-2, ESTF -
Gene ID
- 1326
-
Pathways
- PI3K-Akt Signaling, TCR Signaling
Target
-